In April 2016 Manchester eScholar was replaced by the University of Manchester’s
new Research Information Management System, Pure. In the autumn the University’s research
outputs will be available to search and browse via a new Research Portal. Until then
the University’s full publication record can be accessed via a
temporary portal and the old eScholar content is available to search and browse via this archive.
Related resources
Search for item elsewhere
University researcher(s)
Academic department(s)
Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC).
R. Jotte, J. Von Pawel, D. R. Spigel, M. A. Socinski, M. O'Brien, E. H. Paschold, J. Mezger, M. Steins, L. Bosquée, J. A. Bubis, K. Nackaerts, J. Trigo Perez, P. R. Clingan, W. Schuette, P. Lorigan, M. Reck, M. Domine, F. A. Shepherd, R. McNally, M. F. Renschler
In: ASCO; 02 Jun 2011-06 Jun 2011; Chicago, USA. JCO; 2011.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Use our list of Related resources to find this item elsewhere. Alternatively, request a copy from the Library's Document supply service.
Bibliographic metadata
Type of resource:
Content type:
Type of conference contribution:
Conference contribution title:
Publication date:
Conference title:
ASCO
Conference venue:
Chicago, USA
Conference start date:
2011-06-02
Conference end date:
2011-06-06
Place of publication:
JCO
Institutional metadata
University researcher(s):
Academic department(s):
Record metadata
Manchester eScholar ID:
uk-ac-man-scw:182415
Created by:
Lorigan, Paul
Created:
28th November, 2012, 16:32:12
Last modified by:
Lorigan, Paul
Last modified:
28th November, 2012, 16:51:15